Catalyst Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
08/08/2024 06:12
* Catalyst Pharmaceuticals Inc CPRX.OQ reported quarterly
adjusted earnings of 33 cents per share for the quarter ended
in June, lower than the same quarter last year, when the company
reported EPS of 53 cents. The mean expectation of
seven analysts for the quarter was for earnings of 26 cents per
share. Wall Street expected results to range from 21 cents to 39
cents per share.
* Revenue rose 23.2% to $122.71 million from a year ago;
analysts
expected $111.87 million.
* Catalyst Pharmaceuticals Inc's reported EPS for the
quarter was
33 cents.
* The company reported quarterly net income of $40.79
million.
* Catalyst Pharmaceuticals Inc shares had risen by 4.5% this
quarter and lost 3.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Catalyst
Pharmaceuticals Inc is $26.00
This summary was machine generated from LSEG data August 8 at
05:11 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.26 0.33 Beat
Mar. 31 2024 0.17 0.19 Beat
Dec. 31 2023 0.27 0.31 Beat
Sep. 30 2023 -0.28 -0.29 Missed